Maaged Akiel
Member of The Honor Society of Phi Kappa Phi
From Henrico, VA
From Henrico, VA
Medical/Human Geneticist and cancer researcher who is primarily focusing on understanding the genetics of cancer, molecular mechanisms of carcinogenesis and development of novel targeted anti-cancer therapies for hepatocellular carcinoma (HCC).
Follow Maaged
Maaged Akiel Inducted into The Honor Society of Phi Kappa Phi
The Honor Society of Phi Kappa Phi is pleased to announce that Maaged Akiel of Henrico, Va., was recently initiated into Phi Kappa Phi, the nation's oldest and most selective collegiate honor soci...
December, 08 2014 - Verified by The Honor Society of Phi Kappa Phi
Maaged Akiel was recognized for earning an academic award
Roscoe D. Hughes Award: Awarded to a graduating doctororal candidate who demonstrated outstanding research performance and excellence in Human Genetics.
Spring 2017 -
Added by Maaged
Maaged Akiel was recognized for earning an academic award
Excellence in cancer research award: poster presentation award in recognition of outstanding cancer research.
Summer 2015 -
Added by Maaged
Maaged Akiel was recognized for earning a spot on an honors list
Charles C. Clayton Award: Recognition of outstanding scholarly achievement
Spring 2015 -
Added by Maaged
Maaged Akiel was recognized for earning an academic award
Charles C. Clayton Award: Recognition of outstanding scholarly achievement
Spring 2015 -
Added by Maaged
Maaged Akiel was recognized for earning an academic award
Roscoe D. Hughes Fellowship: Recognition of excellence in graduate studies and research
Spring 2014 -
Added by Maaged
Maaged Akiel was recognized for graduating
Ph.D. Human/Medical Genetics
Added by Maaged
Maaged Akiel was recognized for graduating
M.S. Human/Medical Genetics
Added by Maaged
Doctoral candidate and researcher at VCU School of Medicine
My research activities involve molecular characterization of Hepatocellular carcinoma (HCC) to identify drugable targets that are effective for cancer therapeutics. Moreover, my duties involve establishment and use of genetic mouse models of liver cancer to better understand development and progression of HCC. I also utilize molecular genetic technologies to re-engineer HCC cells for theranostic approaches.
September 2012 - Present
